Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Summit Therapeutics Inc. (SMMT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2023 |
4
| Zanganeh Mahkam (Co-CEO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 15,973,743 shares
@ $1.05, valued at
$16.8M
Bought 804,672 shares
@ $1.05, valued at
$844.9k
Bought 6,748,629 shares
@ $1.05, valued at
$7.1M
|
|
| 03/08/2023 |
4
| Dhingra Ankur (CFO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 196,362 shares
@ $1.05, valued at
$206.2k
|
|
| 03/08/2023 |
4
| DUGGAN ROBERT W (CEO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 376,489,880 shares
@ $1.05, valued at
$395.3M
|
|
| 01/05/2023 |
4
| Booth Robert F. (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 35,000 options to buy
@ $5, valued at
$175k
Granted 32,700 options to buy
@ $5, valued at
$163.5k
|
|
| 01/05/2023 |
4
| Cesano Alessandra (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 35,000 options to buy
@ $5, valued at
$175k
Granted 16,350 options to buy
@ $5, valued at
$81.8k
|
|
| 01/05/2023 |
4
| Mahatme Ujwala (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 35,000 options to buy
@ $5, valued at
$175k
Granted 40,500 options to buy
@ $5, valued at
$202.5k
|
|
| 01/05/2023 |
4
| Clark Kenneth A (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 35,000 options to buy
@ $5, valued at
$175k
Granted 44,400 options to buy
@ $5, valued at
$222k
|
|
| 01/05/2023 |
4
| Soni Manmeet Singh (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 35,000 options to buy
@ $5, valued at
$175k
|
|
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Booth Robert F. (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 200,000 options to buy
@ $1.21, valued at
$242k
Granted 6,250 options to buy
@ $1.21, valued at
$7.6k
|
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2022 |
4
| Gayko Urte (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 400,000 options to buy
@ $1.93, valued at
$772k
|
|
| 01/05/2022 |
4
| Gayko Urte (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.82, valued at
$70.5k
Granted 42,553 options to buy
@ $2.82, valued at
$120k
|
|
| 01/05/2022 |
4
| Mahatme Ujwala (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.82, valued at
$70.5k
Granted 47,872 options to buy
@ $2.82, valued at
$135k
|
|
| 01/05/2022 |
4
| Soni Manmeet Singh (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.82, valued at
$70.5k
Granted 82,446 options to buy
@ $2.82, valued at
$232.5k
|
|
| 01/05/2022 |
4
| Clark Kenneth A (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.82, valued at
$70.5k
Granted 58,510 options to buy
@ $2.82, valued at
$165k
|
|
| 12/17/2021 |
4
| Zanganeh Maky (COO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $4.75, valued at
$71.3k
|
|
| 12/17/2021 |
4
| Maranian Jeffrey R (VP Corporate Controller) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $4.75, valued at
$71.3k
|
|
| 11/16/2021 |
4
| Gayko Urte (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 200,000 options to buy
@ $5.54, valued at
$1.1M
Granted 4,041 options to buy
@ $5.54, valued at
$22.4k
|
|
| 10/12/2021 |
4
| Clark Kenneth A (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 200,000 options to buy
@ $5.03, valued at
$1M
Granted 6,250 options to buy
@ $5.03, valued at
$31.4k
|
|
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Wang Luhua (Director) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Granted 70,000 options to buy
@ $6.77, valued at
$473.9k
Granted 21,096 options to buy
@ $6.77, valued at
$142.8k
|
|
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2020 |
4
| Powell David Jonathan (Chief Scientific Officer) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Exercised 16,616 shares
@ $1.92, valued at
$31.9k
Exercised 12,953 shares
@ $1.79, valued at
$23.2k
Sold 29,569 shares
@ $4.39, valued at
$129.8k
Exercised 13,713 shares
@ $1.79, valued at
$24.5k
Sold 13,713 shares
@ $4.44, valued at
$60.9k
Exercised (in-or-at-the-money) 16,616 options to buy
@ $1.92, valued at
$31.9k
Exercised (in-or-at-the-money) 12,953 options to buy
@ $1.79, valued at
$23.2k
Exercised (in-or-at-the-money) 13,713 options to buy
@ $1.79, valued at
$24.5k
|
|
|
|
|